Main Street Capital CORP·4

May 28, 4:30 PM ET

Lane Brian E. 4

4 · Main Street Capital CORP · Filed May 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Main Street Capital (MAIN) Director Brian Lane Buys 265 Shares via DRIP

What Happened

  • Brian E. Lane, a director of Main Street Capital Corp. (NASDAQ: MAIN), acquired two lots of common stock through the company's dividend reinvestment plan on May 15, 2026. He received 72.309 shares at $50.69 (≈ $3,665) and 192.589 shares at $50.45 (≈ $9,716), for a combined ~264.898 shares costing about $13,381. These are purchases (acquisitions), but the filing notes they resulted from dividend reinvestment rather than an open-market buy.

Key Details

  • Transaction date: 2026-05-15
    • 72.309 shares at $50.69 — value ≈ $3,665
    • 192.589 shares at $50.45 — value ≈ $9,716
    • Total: ~264.898 shares for ≈ $13,381
  • Shares owned after transaction: not specified in the filing
  • Footnote: Shares were acquired under the company’s dividend reinvestment plan; the filing states the transaction is exempt from Section 16 under Rule 16a-11.
  • Filing date: 2026-05-28 — the Form 4 was filed 13 days after the transaction date (later than the typical 2-business-day reporting window).

Context

  • Dividend reinvestment plan (DRIP) purchases are routine: insiders often receive shares automatically when dividends are paid; such transactions do not necessarily indicate a change in insider sentiment. The filing notes the Rule 16a-11 exemption, which covers certain dividend reinvestment transactions. The later filing date is noted above and may reflect administrative timing.

Insider Transaction Report

Form 4
Period: 2026-05-15
Transactions
  • Other

    Common Stock

    [F1]
    2026-05-15$50.69/sh+72.309$3,66552,068.476 total
  • Other

    Common Stock

    [F1]
    2026-05-15$50.45/sh+192.589$9,71652,261.065 total
Footnotes (1)
  • [F1]The reporting person acquired these shares under a dividend reinvestment plan, pursuant to a dividend reinvestment transaction exempt from Section 16 under Rule 16a-11.
Signature
/s/ Jason B. Beauvais, Attorney-in-Fact|2026-05-28

Documents

1 file
  • 4
    form4-05282026_040516.xmlPrimary